Key Points
- Astoriom has acquired Roylance Stability Storage Limited and Roylance Scientific Limited, the Glasgow-based UK operations of life sciences storage provider Sampled.
- The acquisition expands Astoriom’s specialist stability storage and biorepository capacity in the UK.
- Financial terms of the transaction have not been disclosed.
- Customers using Sampled’s Glasgow facility will be supported by Astoriom’s UK operations, including its flagship facility in Rochdale.
- Astoriom said the deal adds technical expertise, broader coverage and operational resilience for the storage of samples, materials and equipment used in scientific research and product development.
- The company provides temperature- and humidity-controlled storage for stability trials, retained samples and long-term biological sample storage.
- Astoriom has more than 30 years of experience in outsourced sample storage services and technical support.
- The Rochdale-based company is backed by UK private equity firm Limerston Capital, which acquired the stability storage business of Source BioScience in 2024 and established Astoriom as a standalone business.
- Astoriom has pursued a buy-and-build strategy through acquisitions in the UK and United States.
- Previous transactions have included MTS Cryo Stores, Cool Repair Scientific UK, Flagship Biosciences’ biorepository operations and Precision Stability Storage.
- Astoriom Chief Executive Will Edwards said maintaining continuity, responsiveness, technical expertise, security, integrity and traceability for stored samples was a priority during the transition.
- Sampled Chief Executive and Chair John DelliSanti said the transaction would allow Sampled to concentrate on biobanking, multiomics and clinical sample management from its US headquarters.
- Astoriom has indicated that it intends to continue expanding through organic growth and further acquisitions.
Astoriom has acquired the UK storage operations of Sampled, taking control of two Glasgow-based businesses and strengthening its specialist sample-storage infrastructure as the Rochdale-based company continues an acquisition-led expansion strategy.
The transaction involves Roylance Stability Storage Limited and Roylance Scientific Limited, which operate as the UK operations of life sciences storage provider Sampled. Business Sale Report reported the transaction on 28 September 2026, describing the deal as an expansion of Astoriom’s stability storage and biorepository capacity across the UK.
Astoriom separately announced the acquisition on 23 September 2026, identifying the acquired businesses and their Glasgow location. The company said the transaction would broaden its coverage and technical capabilities while increasing operational resilience for customers requiring secure storage of samples and other materials used in scientific research and product development.
The financial terms have not been disclosed.
What businesses has Astoriom acquired from Sampled?
The transaction covers Roylance Stability Storage Limited and Roylance Scientific Limited, which formed Sampled’s UK operations in Glasgow.
According to the Business Sale Report, the acquisition includes Sampled’s Glasgow facility and its stability storage and specialist services for pharmaceutical customers.
Astoriom said the acquisition strengthens its specialist storage and sample management capabilities. The company said the enlarged operation would provide broader coverage, additional technical expertise and increased operational resilience.
The businesses operate within a specialised part of the life sciences supply chain. Stability storage is used to preserve samples under controlled environmental conditions so that pharmaceutical and other scientific organisations can assess how products and materials behave over time.
Astoriom said the acquired operation complements its existing capabilities and allows it to support customers with additional infrastructure and expertise.
The company’s existing operations include storage environments controlled for temperature and humidity, supporting stability trials, retained samples and long-term storage of biological materials.
Why has Astoriom acquired Sampled’s UK storage operations?
The acquisition is intended to increase Astoriom’s capacity and geographical coverage while strengthening its ability to provide specialist sample-management services.
Astoriom described the transaction as a way to provide broader coverage, additional expertise and operational resilience. The company said these capabilities are important for safeguarding samples, materials and equipment that can be critical to scientific research and product innovation.
For customers, the transaction is also significant because storage conditions can be an essential part of scientific and pharmaceutical processes. Maintaining appropriate temperature, humidity, monitoring, and inventory controls can be necessary when samples are being held for stability studies or longer-term scientific purposes.
Business Sale Report said Astoriom provides outsourced temperature- and humidity-controlled storage for stability trials, retained samples and long-term biological sample storage.
The company has more than 30 years of experience in outsourced sample storage services and technical support. Its operations extend across the UK, Ireland and the United States.
How will customers using Sampled’s Glasgow facility be supported?
Astoriom said customers currently using services at Sampled’s Glasgow facility will continue to receive support through its UK infrastructure.
The company said its flagship UK facility in Rochdale provides continuous monitoring, inventory controls and business continuity systems.
These systems are particularly relevant to specialist storage operations because customers may depend on controlled environmental conditions and reliable access to stored materials.
Astoriom also emphasised continuity during the transition.
Will Edwards, Chief Executive of Astoriom, said the company’s priority was to maintain continuity of service while building on the foundation established by Sampled.
As reported by Business Sale Report, Edwards said: “Our utmost priority throughout this process is to maintain continuity of service, building upon the strong foundation Sampled has put in place, while providing access to the additional expertise, resources and capabilities available through Astoriom.”
Edwards also highlighted continuity, responsiveness and technical expertise as important factors in maintaining the security, integrity, traceability and required storage conditions of valuable samples.
What did Will Edwards say about Astoriom’s expansion?
Will Edwards said Astoriom’s continued growth reflected demand for its integrated services.
According to the Business Sale Report, Edwards said the acquisition reinforced Astoriom’s commitment to providing high-quality sample storage capabilities in the UK and internationally.
His comments also placed the acquisition within Astoriom’s wider approach to sample management.
The company is seeking to combine specialist storage infrastructure with technical expertise and operational systems that can support customers involved in scientific research and product development.
Astoriom’s expansion therefore goes beyond adding physical storage capacity. The company is also seeking to increase the range of technical resources available to customers while maintaining established standards around sample security and traceability.
Who owns Astoriom?
Astoriom is backed by Limerston Capital, a UK mid-market private equity firm.
Business Sale Report said Limerston Capital acquired the stability storage business of Source BioScience in early 2024 and established it as a standalone company under the Astoriom name.
Since then, Astoriom has pursued a buy-and-build strategy involving acquisitions in both the UK and the United States.
The strategy has allowed the company to expand its geographic footprint and add specialist capabilities to its existing sample-storage operations.
Limerston Capital’s backing is therefore an important part of the corporate context surrounding the latest transaction, although the value of the Sampled deal itself has not been disclosed.
What previous acquisitions has Astoriom completed?
The Sampled transaction is not Astoriom’s first acquisition.
Business Sale Report identified several previous transactions as part of the company’s expansion programme.
These include the acquisition of Nottingham-based MTS Cryo Stores and its sister company, Cool Repair Scientific UK. MTS Cryo Stores provides specialist cryogenic and sample-storage services, while Cool Repair Scientific UK focuses on laboratory refrigeration.
Astoriom has also acquired the biorepository operations of North Carolina-based Flagship Biosciences.
Another transaction involved Precision Stability Storage in the United States. Precision’s facilities expanded Astoriom’s stability-storage capabilities in several US locations.
Astoriom has also expanded its physical infrastructure. Business Sale Report reported that the company launched a cryogenic storage suite and expanded its site in Tramore, Ireland.
These developments show that the Glasgow acquisition forms part of a broader expansion programme rather than being an isolated transaction.
What does the Sampled transaction mean for Sampled?
For Sampled, the sale allows the company to concentrate on other areas of its life sciences business.
Sampled is headquartered in Piscataway, New Jersey, in the United States. The company operates across areas including biobanking, multiomics, and clinical sample management.
John DelliSanti, Chief Executive and Chair of Sampled, said the stability storage and specialised services operated by Roylance Stability Storage had been an important part of the organisation for many years.
As reported by Business Sale Report, DelliSanti said the services had supported pharmaceutical customers across the UK and that Sampled was pleased to see the business begin its next stage with Astoriom.
He also said the transaction would allow Sampled to concentrate on its core strengths in biobanking, multiomics and clinical sample management from its Piscataway headquarters.
This means the transaction changes the corporate ownership of the UK stability-storage operations while allowing Sampled to focus more heavily on its other specialist life sciences services.
Why is stability storage important to pharmaceutical companies?
Stability storage is an important supporting service in pharmaceutical and life sciences research because samples may need to be maintained under specified environmental conditions over extended periods.
The objective can include monitoring how a material, product or biological sample changes over time under controlled conditions.
Astoriom provides storage services covering different temperature and humidity requirements. Such services can support stability programmes, retained samples and long-term biological sample storage.
The company’s model is therefore connected to a wider pharmaceutical and scientific infrastructure in which research organisations, manufacturers and testing businesses require reliable storage and sample-management services.
The Glasgow acquisition adds another UK location and specialist capability to Astoriom’s existing network.
This expansion is particularly relevant to organisations operating in environments where Healthcare Management intersects with scientific operations, regulated processes, quality systems and the management of sensitive materials.
What is Astoriom’s wider acquisition strategy?
The latest deal continues Astoriom’s stated strategy of growing through both acquisitions and organic expansion.
Business Sale Report said the company has consolidated its position in the specialist storage market through a series of transactions and has indicated that it intends to continue scaling.
The company’s acquisition history covers multiple parts of the stability-storage and biorepository market.
Its UK acquisitions have expanded specialist storage and refrigeration capabilities, while US transactions have increased its presence in biorepository and stability-storage services.
Astoriom’s strategy has therefore involved adding businesses with complementary expertise rather than relying solely on expansion of existing facilities.
The latest transaction brings Sampled’s Glasgow operations into that network.
What happens next for Astoriom and Sampled?
The immediate focus following the transaction will be continuity for customers using the Glasgow operation.
Astoriom has stated that it intends to maintain service while providing customers with access to its wider resources and capabilities.
Sampled, meanwhile, will continue focusing on biobanking, multiomics and clinical sample management from its US headquarters.
The transaction also leaves Astoriom with a larger UK platform from which it can provide stabley storage and sample-management services.
The company’s previous acquisitions and its stated intention to continue growing indicate that further corporate activity remains part of its strategy. However, no specific future acquisition has been announced as part of the Sampled transaction.
The deal is therefore significant both for the two Glasgow businesses changing ownership and for the wider development of Astoriom as a specialist life sciences storage provider.
What does the acquisition mean for the UK life sciences storage market?
Astoriom’s acquisition of Sampled’s UK storage operations represents another corporate transaction in the specialist infrastructure supporting pharmaceutical and scientific research.
The deal combines Sampled’s Glasgow stability-storage operation with Astoriom’s established UK infrastructure in Rochdale and its wider international network.
The transaction also illustrates the role of consolidation in specialised business services. Companies operating in highly technical markets can expand by acquiring established facilities, customer relationships and specialist expertise rather than developing every capability internally.
For Astoriom, the acquisition adds two UK businesses and strengthens its position in stability storage and sample management.
For Sampled, the sale enables a greater focus on biobanking, multiomics and clinical sample management.
For customers, Astoriom has stated that continuity of service, sample security, traceability and appropriate storage conditions will remain central during the transition.
The financial details of the transaction remain undisclosed, leaving the operational expansion and strategic rationale as the principal publicly available details of the deal.
As the UK life sciences sector continues to rely on specialist infrastructure for research and product development, developments such as Astoriom’s latest acquisition demonstrate the importance of Healthcare Management and Quality and Productivity in maintaining structured, reliable, and compliant operational environments.